ALISON CECILY FINGER
CIK 1731164 · Chief Commercial Officer · last filed 2026-02-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$374.5K
Companies
3
Total Filings
24
Lifetime Open-Market Net
-$439.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ADMA | Director | 45,619 | $8.21 | $374.5K | $0 | 3 | 2026-02-11 |
| Decibel Therapeutics, Inc. (DBTX) Delisted | Director | 0 | $4.91 | $0 | $0 | 4 | 2023-09-25 |
| bluebird bio, Inc. (BLUE) Delisted | Chief Commercial Officer | 25,862 | $4.97 | $128.5K | -$439.7K | 17 | 2021-01-08 |
Recent Filings · Page 3 of 3
24 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-01-09 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −643 | -$73.1K | EDGAR |
| 2019-01-09 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −476 | -$47.3K | EDGAR |
| 2019-01-07 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −428 | -$42.5K | EDGAR |
| 2018-08-22 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −259 | -$40.9K | EDGAR |
Showing 21–24 of 24
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.